Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ensuring opioid availability: methods and resources.

David E Joranson1, Karen M Ryan

  • 1Pain & Policy Studies Group, University of Wisconsin School of Medicine and Public Health, Paul P Carbone Comprehensive Cancer Center, Madison, WI 53711, USA. joranson@wisc.edu

Journal of Pain and Symptom Management
|May 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flow-cytometric analysis of immune cell populations in patients with depression: relationship with depression severity and electroconvulsive therapy therapeutic outcomes.

Frontiers in cellular neuroscience·2025
Same author

Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysis.

Neuroscience and biobehavioral reviews·2025
Same author

Gene expression of kynurenine pathway enzymes in depression and following electroconvulsive therapy.

Acta neuropsychiatrica·2024
Same author

PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.

The international journal of neuropsychopharmacology·2022
Same author

Electroconvulsive Stimulation in Rats Induces Alterations in the Hippocampal miRNome: Translational Implications for Depression.

Molecular neurobiology·2022
Same author

Blood cell ratios in mood and cognitive outcomes following electroconvulsive therapy.

Journal of psychiatric research·2022
Same journal

Barriers perceived by palliative care fellowships in training physicians from diverse specialties.

Journal of pain and symptom management·2026
Same journal

Health Equity: Foundation of Serious Illness Care.

Journal of pain and symptom management·2026
Same journal

Coping with Breathlessness in Individuals with Lung Diseases: A Systematic Review and Meta-Synthesis.

Journal of pain and symptom management·2026
Same journal

Growing the Next Generation of Hospice and Palliative Medicine Researchers.

Journal of pain and symptom management·2026
Same journal

Topical Amitriptyline, Ketamine, and Lidocaine Cream for Neuropathic Pain Control in Pediatric Oncology Patients.

Journal of pain and symptom management·2026
Same journal

Perceived Stigma, Psychological Distress, and Symptom Burden in Decompensated Cirrhosis.

Journal of pain and symptom management·2026
See all related articles

Government drug control policies often impede patient access to essential pain management, particularly opioid analgesics. Pain and palliative care experts must engage with policymakers to reform regulations and ensure medication availability for medical needs.

Area of Science:

  • Pain Medicine
  • Palliative Care
  • Health Policy
  • Pharmacology

Background:

  • Strict government regulations on opioid analgesics create significant barriers to effective pain management.
  • International drug control treaties sometimes overshadow the obligation to ensure medical and scientific availability of opioids.
  • Disparities in national opioid consumption highlight issues with regulatory frameworks.

Purpose of the Study:

  • To encourage pain and palliative care professionals to understand and engage with government drug control policies.
  • To identify and address impediments to patient access to pain management caused by regulatory policies.
  • To promote examination and reform of national laws governing opioid prescribing.

Main Methods:

Related Experiment Videos

  • Analysis of government drug control policies and their implementation.
  • Engagement with governmental bodies to review and reform regulations.
  • Development of resources and methods by the Pain & Policy Studies Group (PPSG) to assist in policy examination and change.

    • Main Results:

    • Strict regulations, driven by drug control priorities, often hinder access to necessary opioid analgesics for pain relief.
    • Governments may prioritize drug control over ensuring the availability of opioids for legitimate medical use.
    • International bodies are urging governments to revise national laws that restrict opioid prescribing.

    Conclusions:

    • Pain and palliative care fields need to actively engage with drug control policy to improve patient access to pain management.
    • Regulatory reform is crucial to balance drug control with the medical necessity of opioid analgesics.
    • The PPSG offers resources and training to support governments and clinicians in navigating and changing opioid policy.